Shares of Piramal Pharma Ltd slumped 5% on 19 February after the company secured six observations from the US Food and Drug Administration (USFDA). The...
Shares of Piramal Pharma Ltd soared 4% on 23 January after the company’s division Piramal Critical Care announced the launching of Chlorpromazine Hydrochloride Injection, which...
Piramal Pharma witnessed a positive surge of more than 5% in its shares on Thursday following the receipt of an ‘Establishment Inspection Report’ (EIR) from...
Shares of Piramal Pharma plunged nearly 13% in early trading on Thursday after the company reported weak earnings for the December 2022 quarter. The pharmaceutical...